Abstract
Tricyclic antidepressant (TCA) overdoses have become less common over the last 20 years as their overall use has decreased with the advent of safer and more effective antidepressants. Despite their declining popularity in the management of depression, they continue to be used clinically for conditions including the management of neuropathic and chronic pain, cyclic vomiting, nocturnal enuresis, OCD and ADHD. These medications continue to be a leading cause of mortality from intentional ingestions, and account for nearly half of all antidepressant-related deaths (Yates et al. Semin Dial 27(4):381–389, 2014). Common tricyclic antidepressants in use today include amitriptyline, nortriptyline, imipramine, desipramine and doxepin.
The management of tricyclic antidepressant poisonings can be quite challenging. Since they exert their toxicity through several different mechanisms an understanding of their pharmacology is imperative. TCAs all have inherent anticholinergic effects that may cause tachycardia, altered mental status and seizures. They can cause profound hypotension through alpha-adrenergic blockade as well as catecholamine depletion through reuptake inhibition. Finally, they block fast sodium channels in the cardiac conduction system leading to myocardial depression and ventricular arrhythmias (Agrawal et al. J Emerg Med 34(3):321–325, 2008).
Successful treatment of patients poisoned by tricyclic antidepressants hinges on prompt diagnosis and recognition of the classic EKG findings associated with their toxicity. GI decontamination should be considered when patients present within the first 1–2 h following an overdose. Serum alkalinization with sodium bicarbonate is considered the first-line treatment when signs of cardiotoxicity develop. Patients with refractory hypotension may require vasopressor support.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yates C, Galvao T, Sowinski KM, et al. Extracorporeal treatment for tricyclic antidepressant poisoning: recommendations from the EXTRIP Workgroup. Semin Dial. 2014;27(4):381–9.
Agrawal P, Nadel ES, Brown DF. Tricyclic antidepressant overdose. J Emerg Med. 2008;34(3):321–5.
Harrigan RA, Brady RJ. ECG abnormalities in tricyclic antidepressant ingestion. Am J Emerg Med. 1999;17(4):387–93.
Boehnert MT, Lovejoy Jr FH. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med. 1985;313(8):474–9.
Wolfe TR, Caravati EM, Rollins DE. Terminal 40-ms frontal place axis as a marker for tricyclic antidepressant overdose. Ann Emerg Med. 1989;18:348–51.
Karkkainen S, Neuvonen PJ. Pharmacokinetics of amitriptyline influenced by oral charcoal and urine pH. Int J Clin Pharmacol Ther Toxicol. 1986;24:326–32.
Dargan PI, Colbridge MG, Jones AL. The management of tricyclic antidepressant poisoning : the role of gut decontamination, extracorporeal procedures and fab antibody fragments. Toxicol Rev. 2005;24(3):187–94.
Bosse GM, Barefoot JA, Pfeifer MP, Rodgers GC. Comparison of three methods of gut decontamination in tricyclic antidepressant overdose. J Emerg Med. 1995;13(2):203–9.
Sasyniuk BI, Jhamandas V, Valois M. Experimental amitriptyline intoxication: treatment of cardiac toxicity with sodium bicarbonate. Ann Emerg Med. 1986;15(9):1052–9.
Blackman K, Brown SF, Wilkes GJ. Plasma alkalinization for tricyclic antidepressant toxicity: a systematic review. Emerg Med. 2001;13:204–10.
Hoffman JR, McElroy CR. Bicarbonate therapy for dysrhythmia and hypotension in tricyclic antidepressant overdose. Western J Med. 1981;134(1):60–4.
Vernon DD, Banner W, Garrett JS, Dean JM. Efficacy of dopamine and norepinephrine for treatment of hemodynamic compromise in amitriptyline intoxication. Crit Care Med. 1991;19(4):544–9.
Tran TP, Panacek EA, Rhee KJ, Foulke GE. Response to dopamine vs norepinephrine in tricyclic antidepressant-induced hypotension. Acad Emerg Med. 1997;4(9):864–8.
Barry JD, Durkovich DW, Williams SR. Vasopressin treatment for cyclic antidepressant overdose. J Emerg Med. 2006;31(1):65–8.
Ellison DW, Pentel PR. Clinical Features and consequences of seizures due to cyclic antidepressant overdose. Am J Med. 1989;7(1):5–10.
Merigian KS, Browning RG, Leeper KV. Successful treatment of amoxapine-induced refractory status epilepticus with propofol. Acad Emerg Med. 1995;2(2):128–33.
Ozcon MS, Weinberg G. Intravenous lipid emulsion for the treatment of drug toxicity. J Intensive Care Med. 2014;29(2):59–70.
Varney SM, Bebarta VS, Vargas TE, Boudreau S, Castaneda M. Intravenous lipid emulsion therapy does not improve hypotension compared to sodium bicarbonate for tricyclic antidepressant toxicity: a randomized, controlled pilot study in a swine model. Acad Emerg Med. 2014;21(11):1212–9.
Harvey M, Cave G. Intralipid outperforms sodium bicarbonate in a rabbit model of clomipramine toxicity. Ann Emerg Med. 2007;49(2):178–85, 185.e1–4.
Litonius E, Niiya T, Neuvonen PJ, Rosenberg PH. No antidotal effect of intravenous lipid emulsion in experimental amitriptyline intoxication despite significant entrapment of amitriptyline. Basic Clin Pharmacol Toxicol. 2012;110(4):378–83.
Blaber MS, Khan JN, Brebner JA, Mccolm R. “Lipid rescue” for tricyclic antidepressant cardiotoxicity. J Emerg Med. 2012;43(3):465–7.
Kiberd MB, Minor SF. Lipid therapy for the treatment of a refractory amitriptyline overdose. CJEM. 2012;14(3):193–7.
Agarwala R, Ahmed SZ, Wiegand TJ. Prolonged use of intravenous lipid emulsion in a severe tricyclic antidepressant overdose. J Med Toxicol. 2014;10:210–4.
Engels PT, Davidow JS. Intravenous fat emulsion to reverse haemodynamic instability from intentional amitriptyline overdose. Resuscitation. 2010;81(8):1037–9.
Weinberg GL. Lipid emulsion infusion: resuscitation for local anesthetic and other drug overdose. Anesthesiology. 2012;117(1):180–7.
McCabe JL, Cobaugh DJ, Menegazzi JJ, Fata J. Experimental tricyclic antidepressant toxicity: a randomized, controlled comparison of hypertonic saline solution, sodium bicarbonate, and hyperventilation. Ann Emerg Med. 1996;32(3):329–33.
Mckinney PE, Rasmussen R. Reversal of severe tricyclic antidepressant-induced cardiotoxicity with intravenous hypertonic saline. Ann Emerg Med. 2003;42(1):20–4.
Foianini A, Weigand TJ, Benowitz N. What is the role of lidocaine or phenytoin in tricylic antidepressant-induced cardiotoxicity. Clin Toxicol. 2010;48(4):325–30.
Knudsen K, Abrahamsson J. Effects of magnesium sulfate and lidocaine in the treatment of ventricular arrhythmias in experimental amitriptyline poisoning in the rat. Crit Care Med. 1994;22(3):494–8.
Pentel PR, Benowitz NL. Tricyclic antidepressant poisoning—management of arrhythmias. Med Toxicol. 1986;1:101–21.
Emamhadi M, Mostafazadeh B, Hassanijirdehi M. Tricyclic antidepressant poisoning treated by magnesium sulfate: a randomized, clinical trial. Drug Chem Toxicol. 2012;35(3):300–3.
Sarisoy O, Babaoglu K, Tukay S, et al. Effect of magnesium sulfate for treatment of ventricular tachycardia in amytriptyline intoxication. Pediatr Emerg Care. 2007;23:646–8.
Knudsen K, Abrahamsson K. Magnesium sulfate in the treatment of ventricular fibrillation in amitriptyline poisoning. Eur Heart J. 1997;18(5):881.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Minges, P.G., Shaffer, R.W. (2017). Diagnosis and Management of Tricyclic Antidepressant Ingestion. In: Hyzy, R. (eds) Evidence-Based Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-43341-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-43341-7_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43339-4
Online ISBN: 978-3-319-43341-7
eBook Packages: MedicineMedicine (R0)